Bayer Dinner 

Free Dinner 

Topic: Post Hoc Subgroup Analysis: Kogenate FS® Patients Transitioned to Jivi® or Kovaltry® as Part of Clinical Trials

Overview: Review efficacy and safety data from Kovaltry and Jivi clinical studies, including data on patients who transitioned from Kogenate FS

Speaker:  Ryan Moulton

Come enjoy learning some information and great company! Hope to see you there! REGISTER below!